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Background: Activity of the Transforming growth factor-β (TGFβ) pathway is essential to the establishment of body
axes and tissue differentiation in bilaterians. Orthologs for core pathway members have been found in all
metazoans, but uncertain homology of the body axes and tissues patterned by these signals raises questions about
the activities of these molecules across the metazoan tree. We focus on the principal canonical transduction
proteins (R-Smads) of the TGFβ pathway, which instruct both axial patterning and tissue differentiation in the
developing embryo. We compare the activity of R-Smads from a cnidarian (Nematostella vectensis), an arthropod
(Drosophila melanogaster), and a vertebrate (Xenopus laevis) in Xenopus embryonic assays.
Results: Overexpressing NvSmad1/5 ventralized Xenopus embryos when expressed in dorsal blastomeres, similar to
the effects of Xenopus Smad1. However, NvSmad1/5 was less potent than XSmad1 in its ability to activate
downstream target genes in Xenopus animal cap assays. NvSmad2/3 strongly induced general mesendodermal
marker genes, but weakly induced ones involved in specifying the Spemann organizer. NvSmad2/3 was unable to
induce a secondary trunk axis in Xenopus embryos, whereas the orthologs from Xenopus (XSmad2 and XSmad3)
and Drosophila (dSmad2) were capable of doing so. Replacement of the NvSmad2/3 MH2 domain with the Xenopus
XSmad2 MH2 slightly increased its inductive capability, but did not confer an ability to generate a secondary body
axis.
Conclusions: Vertebrate and cnidarian Smad1/5 have similar axial patterning and induction activities, although
NvSmad1/5 is less efficient than the vertebrate gene. We conclude that the activities of Smad1/5 orthologs have
been largely conserved across Metazoa. NvSmad2/3 efficiently activates general mesendoderm markers, but is
unable to induce vertebrate organizer-specific genes or to produce a secondary body axis in Xenopus. Orthologs
dSmad2 and XSmad3 generate a secondary body axis, but activate only low expression of organizer-specific genes
that are strongly induced by XSmad2. We suggest that in the vertebrate lineage, Smad2 has evolved a specialized
role in the induction of the embryonic organizer. Given the high level of sequence identity between Smad
orthologs, this work underscores the functional importance of the emergence and fixation of a few divergent
amino acids among orthologs during evolution.
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In developing animal embryos the Transforming Growth
Factor-β (TGFβ) superfamily of ligands and signaling
pathways regulate cell fate decisions, pattern formation,
growth and organogenesis. Canonical TGFβ signals are
transduced by Smad proteins operating in either of two
major signaling branches, the bone morphogenetic* Correspondence: gerald.h.thomsen@stonybrook.edu
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distribution, and reproduction in any mediumprotein (BMP) and Activin/Nodal pathways. The unique
receptor-regulated Smad (R-Smad) protein sequences
determine the specificity of each R-Smad for upstream
receptors and downstream cofactors and target genes.
Recently, orthologs of the core members of the TGFβ
pathway have been identified outside of Bilateria, in ani-
mals that lack the degree of complexity seen in bilaterian
symmetry and tissue-types [1]. These animals possess
TGFβ genes even though none have a true dorsoventral
axis or mesoderm, and the sponge lacks definitive germ
layers altogether. TGFβ superfamily ligands and theirtral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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choanoflagellate Monosiga brevicollis (the eukaryotic
outgroup to Metazoa), which indicates that this growth
factor system is restricted to Metazoa [1-3].
Discovery of key conserved developmental gene path-
ways has led to the paradigm of a shared ‘genetic toolkit’:
a gene network that generates the variety of animal body
forms by differential deployment. Work has been done
to reveal the evolutionary history of many gene networks
by mapping their presence or absence onto phylogenetic
trees. It has been tempting to reconstruct the presence
of morphological features along with the presence of a
gene network in animal ancestors at key nodes, such as
the ancestors of Bilateria and Eumetazoa [4]. However,
some authors reject these reconstructions on the
grounds that conservation of genes involved in core gen-
etic regulatory networks does not necessitate the pres-
ence of the particular morphologies known to be
regulated by these networks [5]. These disagreements
highlight the need for functional testing when studying
the meaning of these orthologous gene networks.
We approached the question of functional conserva-
tion by testing the ability of non-bilaterian gene pro-
ducts to function in a developing vertebrate in vivo. We
focus on the Smad proteins, which operate both as intra-
cellular transducers of TGFβ family receptor signals and
as transcription factors. Failure of Smad signaling and
abnormal downstream gene regulation causes funda-
mental disruption of body axes and cell fate determi-
nation. Three subtypes of Smads are involved in TGFβ
signaling [6-8], the receptor-regulated (R), the common
(Co) and the inhibitory Smads (I). R-Smads are phos-
phorylated at a C-terminal pair of serine residues when
an extracellular ligand binds to Type I and II receptors,
forming a signaling complex. Phosphorylated R-Smads
then bind to a Co-Smad to form a trimeric complex that
facilitates additional interactions with transcription fac-
tors on promoter elements of target genes. Smad signal-
ing is regulated at the level of receptors and R-Smad/
Co-Smad complexes by I-Smads [6]. With a few excep-
tions, most non-vertebrate taxa have four Smad genes,
an R-Smad in the Activin/Nodal pathway (AR-Smad), an
R-Smad in the BMP pathway (BR-Smad), a Co-Smad,
and an I-Smad. Vertebrates typically have multiple co-
pies of each due to gene duplication events [3], which
raise major questions about whether duplicated Smads
have retained ancestral activities and/or evolved diver-
gent functions.
Smads are considered highly conserved in their bio-
chemical and biological functions, and they are structu-
rally defined by the presence of two characteristic ‘MAD
homology’ (MH) domains that determine functionality.
Generally speaking, the N-terminal MH1 domain binds
directly to DNA and contains a nuclear localization signal,and the C-terminal MH2 domain contains binding sites
for the numerous potential protein co-factors that make
up the transcriptional complexes (Figure 1A) [6,8]. R-
Smad proteins terminate at a consensus SSXS polypeptide,
of which the last two serines become phosphorylated in
response to receptor activation [6] (see Additional file 1).
Co- and I-Smads lack this consensus. The MH1 and MH2
domains are separated by a linker region that can be
highly variable among species and even Smad subtypes,
but serves important regulatory functions by providing
sites for non-TGFβ receptor-driven phosphorylation and
targeting by E3 ubiquitin ligases [8].
Vertebrates have three BR-Smads that transduce BMP
signals - Smad1, Smad5, and Smad8/9 (see Additional
file 1). In Xenopus, XSmad1 is the major embryonic
intracellular transducer of BMP signals, and its ectopic
expression in dorsal embryonic regions mimics the
effects of BMP overexpression such as loss of dorsal cell
identity resulting in tadpoles that are almost entirely
composed of ventral tissues, lacking heads and neural
tissues as a consequence of respecification [9]. Func-
tional conservation of BR-Smad orthologs across taxa
has been shown by the ectopic expression of dMad, the
XSmad1 ortholog from Drosophila, that when injected
dorsally into Xenopus embryos causes the same cata-
strophic loss of head and neural tissues as overexpres-
sion of the native XSmad1 [9].
Xenopus laevis, like most vertebrates, has two AR-Smads
in the Activin/Nodal pathway - Smad2 and Smad3. Overex-
pression of XSmad2 induces dorsal mesoderm in pluripo-
tent Xenopus animal caps [10] and a secondary body
(trunk) axis in whole Xenopus embryos [11]. A dominant
negative form of XSmad2 inhibits anterior mesoderm de-
velopment and decreases induction of organizer genes such
as chordin, goosecoid, and cerberus [12]. Less is known
about the specific function of XSmad3, but evidence
suggests functional specialization of Smad2 and Smad3
[13]. In Xenopus, XSmad2 is present maternally and
throughout gastrulation, neurulation and tadpole stages
and is significantly more abundant than XSmad3, which is
present as low abundance maternal RNA that disappears
in early gastrulation and reappears in tailbud tadpoles in
specialized tissues [14]. The potential for these genes to
have discrete functions is even more pronounced in the
mouse. Smad2 knockout mice fail to gastrulate and exhibit
early embryonic lethality, whereas Smad3 knockouts are
born alive but die within 1 to 10 months due to cancer
and immune deficiencies [15]. Zebrafish have three copies
of the AR-Smads - Smad2, Smad3a, and Smad3b [16].
Reports on their function and relative developmental im-
portance are conflicting, but they appear to be distinct as
well [16-18]. However, whether this distinction is based
on regulatory sequences or primary protein sequence is
unclear.
Figure 1 R-Smads are defined by two conserved protein domains. (A) Diagram of a typical R-Smad showing the two conserved domains
(MH1 and MH2) with important regions noted. (B) A table of pairwise percent identity of the MAD homology domains and the non-conserved
linker regions of Xenopus and Nematostella R-Smads [see Additional file 1 for a detailed amino acid alignment and Additional file 2 for a table of
GenBank accession numbers]. (C) Alignment of relevant sections of the Smad1/5/8 linker regions from multiple taxa. The Smurf1 site PPXY motif
is highlighted in cyan, MAPK recognition sites are highlighted in yellow, and GSK3 consensus sites are highlighted in green. (D) Alignment of
relevant sections of the Smad2/3 linker regions from multiple taxa. The Smurf2 site PPXY motif is highlighted in cyan, MAPK recognition sites are
highlighted in yellow, and proline-directed kinase sites are highlighted in magenta. Underlined sequences in (C) and (D) indicate consensus sites
identified for the particular protein and species in the literature; all other highlights reflect our inferences based on the alignments.
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mals have just two R-Smads. With respect to the
Activin-like pathway in Drosophila, an AR-Smad called
dSmad2 has been described but its activity and signifi-
cance appears to be quite different than Smad2/3 in ver-
tebrates [19,20]. The protein dSmad2 is activated by the
Activin-type receptor Baboon, and loss of Baboon func-
tion (and thus dSmad2 function) causes minor problems
with cell proliferation and growth, but does not affect
body patterning [20]. In fact, dSmad2 overexpression in
prospective ectoderm of Xenopus animal caps causes
Activin-like induction of mesoderm [19], but the level to
which dSmad2 shares functional homology with verte-
brate Smad2 or Smad3 was not tested.
Smad family members have been identified in all meta-
zoan clades, but the extent to which there is (or is not)
functional conservation among the Smads, particularlyacross highly divergent taxa such as non-bilaterians and
chordates, is an important question to answer that will
inform the evolution of this protein family. In the present
study, we used qualitative and quantitative methods to
examine whether the functions of the R-Smads have
been conserved sufficiently during metazoan evolution
to allow R-Smads from a cnidarian to participate in the
TGFβ signal transduction network during early verte-
brate embryogenesis. We have chosen two exemplar taxa
for this study, Xenopus laevis (the African clawed frog, a
model organism for functional studies) and the model
cnidarian Nematostella vectensis (the starlet sea ane-
mone). The Nematostella BR-Smad ortholog, NvSmad1/5,
has been identified, and a Nematostella AR-Smad ortholog
(NvSmad2/3) was found previously and evaluated in a
phylogenetic analysis of the NvSmad family, but it has not
been experimentally tested for function [2].
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tostella and Drosophila R-Smad orthologs to induce ex-
pression of downstream pathway genes and pattern
tissues in the Xenopus embryo. We also probe the acti-
vities of individual Smad domains using chimeric con-
structs from Xenopus Smad2 and Nematostella Smad2/
3. We find that cnidarian R-Smad proteins activate BMP
and Activin/Nodal responses, but not at the efficiency of
the native Xenopus proteins. However, we reveal qualita-
tive differences in the ability of NvSmad2/3 to function
in the developing vertebrate. Notably, vertebrate Smad2
and Smad3 have different signaling abilities, and only
the bilaterian orthologs of Smad2/3 are capable of indu-
cing ectopic axial structures in Xenopus embryos. Our
findings show a deep conservation of fundamental Smad
activities across 650 million years of animal evolution,
but divergence in the smaller scale fine-tuning of gene
activation, reflecting different evolutionary histories of
the two major Smad TGFβ signaling pathways.
Methods
Xenopus, Nematostella, and Drosophila clones
The Xenopus Smad1, Smad2, and Smad3 and NvSmad1/
5 clones were already available in the Thomsen Lab
(Stony Brook University). NvSmad2/3 was cloned di-
rectly out of cDNA prepared from total RNA of Nema-
tostella planulae. The primers were designed from a
predicted protein sequence [NCBI: XP_001631607],
which was identified using a Basic Local Alignment
Search Tool (BLAST) search with XSmad2 sequence
(forward primer: 50 ATGACTTCCCTGTTGCCT 30, re-
verse primer: 50 CTACGATACCGAGGAGAT 30). The
PCR amplification was carried out with Platinum™ Taq
DNA Polymerase High Fidelity ( Life Technologies, Invi-
trogen, Grand Island, NY). The PCR conditions were as
follows: 94°C for 2 minutes (1 cycle); 94°C for 30 se-
conds, 56°C for 30 seconds, 68°C for 1.5 minutes
(40 cycles); and 68°C for 2 minutes. The Drosophila
dSmad2 (or Smox) clone was a gift from the lab of
Dr. Spyros Artavanis-Tsakonas (Harvard University) and
the Drosophila Protein Interaction Map group. All
clones were subcloned into the plasmid pCS2 containing
three HA tags 50 of the gene start site. The XSmad2-
ΔExon3 clone was a gift from the laboratory of Malcolm
Whitman at Harvard University.
Sequence analysis
Once subcloned, all clones were sequenced and checked
against the correct protein sequence from GenBank. To
create the alignments and pairwise comparisons used for
Figure 1 and Additional file 1, we aligned the amino acid
sequences by hand in MacVector (MacVector, Inc., Cary,
NC), saved them as subdomain alignments, and opened
them in ClustalW (European Bioinformatics Institute,Cambridge, UK, http://www.clustal.org) to calculate pair-
wise percent identity scores [see Additional file 2 for
accession numbers].
Chimera assembly
Amino acid boundaries for MAD Homology domains in
XSmad2 and NvSmad2/3 are given in their entries at
NCBI. MH1 chimera: [XSmad2: 1 to 172] + [NvSmad2/
3: 131 to 423]. Linker chimera: [NvSmad2/3: 1 to 130] +
[XSmad2: 173 to 267] + [NvSmad2/3: 224 to 423]. MH2
chimera: [NvSmad2/3: 1 to 223] + [XSmad2: 268 to 467].
In order to create the chimeric constructs, fragments
were generated by PCR from XSmad2 and NvSmad2/3
clones [see Additional file 3 for primer locations and
sequences]. The PCR amplification was carried out with
Platinum™ Pfx DNA Polymerase from (Life Technolo-
gies). The PCR conditions were as follows: 94°C for
4 minutes (1 cycle), 94°C for 30 seconds, 55°C for
30 seconds, 68°C for 1 minute (35 cycles) and 68°C for
30 minutes. Primers were designed to amplify the desired
region from one species and add approximately 10
nucleotides of the intended adjacent region of the other
species, to generate fragments that would partially over-
lap within the chimeric product. Chimeric sequences
were then generated by placing the appropriate frag-
ments together in a PCR reaction and adding the primers
corresponding to the ends of the desired chimeras. The
fragments were ligated into pGEM-T vector and sub-
cloned into an HA-tagged pCS2 vector. Chimeras were
verified by sequencing.
Messenger RNA synthesis
Clones were linearized and messenger RNA (mRNA) for
microinjection was made from each clone using the
Amplicap™ SP6 High Yield Message Maker kit (Epicentre
Biotechnologies, Madison, WI). The mRNA was purified
using a Qiagen RNeasy kit (Qiagen Inc., Valencia, CA),
tailed using the Poly(A) Polymerase Tailing Kit (Epicentre
Biotechnologies), and purified again before use.
Xenopus embryo injections
Smad1/5 phenotypes were generated by injecting 2 ng of
mRNA (in 10 nl of nuclease-free water) into the mar-
ginal zone of both blastomeres at 4-cell stage (for a total
of 4 ng). Smad2/3 phenotypes were generated by inject-
ing 0.5 ng (in 5 nl) into the marginal zone of one ventral
vegetal blastomere at 8-cell stage [11,12,21]. Embryos
were scored at neurula stage and allowed to grow until
tadpole stage. Animal cap assays were performed by
injecting 2 ng (in 10 nl) into the animal pole of each
blastomere at 2-cell stage (for a total of 4 ng). All injec-
tions were performed in at least three different frogs and
used for analysis. This research was compliant with the
National Institutes of Health (NIH) Institutional Animal
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by the Stony Brook University Internal Review Board.
Translation assessment
Western blotting was performed to check for expression
of the Heamaglutinin Antigen (HA) peptide tags and
equalize translation levels. Embryos were lysed with a
pipet tip in PBS 1% Triton at stage 11, at the same time
as the animal caps from the same experiment were ready
for harvesting. Lysates were spun at 4°, and soluble pro-
tein was mixed 1:1 with loading buffer and loaded in a
5% polyacrylamide gel. An Anti-HA primary antibody
from Santa Cruz (sc-805) used at 1:500; the loading con-
trol was Abcam anti-β-Actin (ab 8229), used at 1:750.
The secondary antibody was Alexa Fluor 680 goat anti-
rabbit IgG from Life Technologies (A-21109), used at
1:10,000 [see Additional file 4 for full western blots and
loading controls].
Xenopus animal cap assay
Messenger RNA was injected into the animal pole of
both blastomeres at 2-cell stage; animal caps were har-
vested at stage 8 and cultured in 0.5× Marc’s Modified
Ringers (MMR) buffer until stage 11. Cells were lysed
with Proteinase K and total RNA was extracted from the
animal caps and whole embryo controls using phenol:
chloroform extraction, followed by ethanol precipitation.
Next, cDNA was synthesized using 1 μg of total RNA
and SuperScript II Reverse Transcriptase enzyme from
Invitrogen (Life Technologies). Then, cDNA samples
were analyzed on a Roche Diagnostics LightCycler 480
System using SYBR™ Green Mastermix I from Roche
Diagnostics (Indianapolis, IN). Animal cap cDNA was
compared to cDNA from a whole embryo, representing
the endogenous expression levels. For each primer pair
in each experiment, serial dilutions of whole embryo
cDNA were used to create the standard curve to which
all samples were compared in order to calculate concen-
tration of PCR product. Once concentrations were
acquired and imported into Excel, raw values were nor-
malized to the level of Ornithine Decarboxylase (ODC),
a housekeeping gene. See Additional file 5 for a table of
LightCycler primer sequences and quantitative RT-PCR
(qPCR) conditions, and their references.Results and discussion
Nematostella Smads contain the highly conserved
MAD-homology domains that define bilaterian Smads
First, we revisited the presence and identities of R-Smads in
Nematostella. Previous work identified one AR-Smad
(NvSmad2/3) and one BR-Smad (NvSmad1/5) [2,3], and
our re-examination of genomic and cDNA sequences con-
firmed those earlier identifications, but since the NvSmad2/3 ortholog was only reported as a predicted protein [NCBI:
XP_001631657], we isolated a full-length copy of this
cDNA (see Methods). We then performed pairwise align-
ments of all R-Smad orthologs from Xenopus and Nematos-
tella to validate their relationships and highlight their
unique features [see Additional file 1 and Additional file 2
for detailed alignments and accession numbers].
We found that the amino acid sequences of the MAD
homology domains are highly conserved between Xenopus
and Nematostella (Figure 1B). The N-terminal MH1
DNA-binding domain is more conserved in the Smad1/5
category (86%) than in the Smad2/3 category (78 to 79%).
The C-terminal MH2 protein-interacting domain is the
most conserved in each R-Smad category, and is equally
conserved between Smad1/5 and Smad2/3 (88 to 89%).
The linker region is less conserved than the MAD ho-
mology domains, 20% in Smad1/5 and 33 to 34% in
Smad2/3. Since the linker region is more variable yet con-
tains important sites for post-translational regulation, we
performed a second, more inclusive alignment of linker
domains in order to investigate the status of several im-
portant sites. We included R-Smad orthologs from the
human and from Drosophila melanogaster in this part of
this analysis [see Additional file 2 for accession numbers].
Figure 1C and D show alignments of the important resi-
dues of the linker regions.
The human Smad1/5/9 linker contains four conserved
proline-X-serine-proline (PXSP) consensus sites for
MAPK phosphorylation [22], which are putatively
present in Xenopus Smad8a and 8b (Figure 1C, yellow).
The Drosophila dMad linker contains two conserved
MAPK sites (Figure 1C, underline and yellow) [23], and
the NvSmad1/5 linker shows one potential site
(Figure 1C). With the exception of human Smad9b,
vertebrate and Drosophila Smad1/5/8 orthologs share
the PPXY motif that binds Smurf1, an E3 ubiquitin
ligase that, once bound, will bring about ubiquitin-
mediated degradation of these Smads [24] (Figure 1C,
cyan). The linker of NvSmad1/5, however, lacks this site
(Figure 1C). The dMAD linker also contains eight
serine/threonine phosphorylation sites for GSK3 [23],
which show variable conservation in the other orthologs
(Figure 1C, green). The vertebrate orthologs contain seven
of these predicted sites, and the linker of NvSmad1/5 con-
tains potentially five of them.
The human Smad2 and Smad3 orthologs contain a
MAPK consensus site [25] that is also found in Xenopus
orthologs, putatively in dSmad2, and partially in
NvSmad2/3 (Figure 1D, yellow). With the exception of
NvSmad2/3, the linkers of all Smad2/3 orthologs possess
a PPXY motif, which allows targeting by Smurf2 for
ubiquitin-mediated degradation [26] (Figure 1D, cyan).
The human Smad2 and Smad3 orthologs contain three
serine/proline phosphorylation target residues [27,28] that
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two of which appear in NvSmad2/3 (Figure 1D, magenta).
These analyses illustrate that cnidarian R-Smad linker
regions may have fewer points of regulation compared to
bilaterian R-Smads, suggesting that NvSmad1/5 could be
regulated in a different manner from bilaterian orthologs.
Overexpression of NvSmad1/5 causes ventralization
phenotypes in Xenopus embryos
Bilaterian BR-Smad orthologs can ventralize Xenopus
embryos when ectopically expressed in dorsal tissues.
We tested whether NvSmad1/5 could function similarly
when ectopically expressed in vivo in Xenopus embryos.
We compared the phenotype from ectopic expression of
NvSmad1/5 to that of XSmad1 (the Smad5 gene is not
present in Xenopus laevis, and XSmad8 transcripts are
scarce during gastrulation [29]). We found that ectopic
dorsal expression of NvSmad1/5 generated the hallmarks
of BMP overexpression: ventralization and obliteration





















Figure 2 Phenotypes caused by ectopic NvSmad1/5 mRNA mimic phe
mRNA into the two dorsal blastomeres of a four-cell Xenopus embryo caus
tadpoles are shown at stage 34. (A) Shows normal development in Xenopu
XSmad1 mRNA and show severe ventralization. (C) Tadpoles injected with
phenotype. Severity of phenotype was scored according the Dorso-Anteriotadpoles had obvious head and neural structures
(Figure 2A), whereas tadpoles that had been injected
with XSmad1 mRNA showed a range of ventralization
phenotypes, the most severe of which are shown in
Figure 2B. Injection of NvSmad1/5 mRNA also showed
a range of ventralization effects, the most severe of
which are shown in Figure 2C.
To quantify the range of effects, we used Kao and Eli-
son’s DorsoAnterior Index (DAI) to score the severity of
the ventralization phenotypes on a scale of 0 (most se-
verely ventralized) to 5 (normal) [30]. Overall, the
XSmad1 phenotypes scored as more severe than the
NvSmad1/5 phenotypes (Figure 2D). The weighted
means of the XSmad1 and NvSmad1/5 phenotypes were
0.89 and 1.77, respectively. The standard deviation of
the XSmad1 scores was less than that of the NvSmad1/5
scores, 1.0 and 1.4 respectively. The XSmad1 overex-
pression phenotype is overall more severe and has less
range, whereas the NvSmad1/5 phenotype is less severe








notypes caused by XSmad1 mRNA. Microinjection of NvSmad1/5
es similar ventralization phenotypes as injection of XSmad1 mRNA. All
s tadpoles. In contrast, tadpoles in (B) were injected with 4 ng of
4 ng NvSmad1/5 show a similar but less severe ventralization
r Index (DAI) [30]. (D) Shows the DAI scores graphically.
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embryo and successfully generates the expected ventrali-
zation effects of BMP activity, but it is less potent than
the native XSmad1 protein under the same conditions.NvSmad1/5 induces downstream BMP marker gene
expression in Xenopus
The observation that ectopic expression of NvSmad1/5
and XSmad1 results in similar ventralization phenotypes
led us to compare their inductive activity more precisely,
and determine whether NvSmad1/5 has the ability to
initiate similar downstream gene expression in Xenopus.
To do this, we used Xenopus animal cap assays to com-
pare the expression levels of ventral marker genes
known to be downstream of BMP signaling. We used
tagged expression vectors and western blotting to con-
firm equal protein translation levels before performing
RT-PCR analysis (Figure 3A) [see Additional file 4 for
western blot loading controls].
In three out of four cases, NvSmad1/5 induced expres-
sion at a level significantly higher than that of the unin-
jected animal caps (Figure 3B). NvSmad1/5 was able to
induce downstream BMP pathway members Vent1, Msx1,
and Xhox3 at levels higher than in uninjected animal caps,
yet at roughly half the levels induced by the nativeFigure 3 NvSmad1/5 induces expression of downstream BMP pathwa
NvSmad1/5 at the 2-cell stage, stage 11 animal caps show elevated express
animal cap assay procedure; animal caps were processed for western blot
and Faber stage 11). The western blot shows protein translation levels in in
showing the 58-kDa band). XSmad1 and NvSmad1/5 show equal levels of
signal. (B) Real-time quantitative RT-PCR (qPCR) shows fold induction levels
compared to the uninjected whole embryos. Uninjected Xenopus animal ca
with NvSmad1/5 are shown. The Y-axis of all RT-PCR graphs shows the fold
indicate the standard error.XSmad1 protein. However, in all cases, NvSmad1/5 failed
to induce expression equal to endogenous levels in the
whole embryo (set as 1.0 on the Y-axis for all RT-PCR ana-
lyses). We were not able to see a clear induction response
by Vent2, which may be due to high levels of endogenous
Vent2 expression. Thus, despite the absolute differences in
activity between NvSmad1/5 and XSmad1, NvSmad1/5
can initiate transcription of Xenopus BMP target genes.NvSmad2/3 induces expression of a subset of markers
of the Activin/Nodal pathway
In order to test the functional conservation of verte-
brate and cnidarian AR-Smad orthologs, we examined
the ability of NvSmad2/3 to initiate Activin/Nodal sig-
naling in the Xenopus animal cap. Equal protein trans-
lation levels were confirmed using western blotting
before RT-PCR analysis (Figure 4A) [see Additional file
4 for western blot loading controls]. Unlike the uni-
formity of marker induction by NvSmad1/5, the induc-
tion response to XSmad2 and NvSmad2/3 showed two
clear patterns: for some markers NvSmad2/3 showed
only a fraction of the inductive power of the native
XSmad2, whereas for other markers, NvSmad2/3 was
equal to or greater than XSmad2 in its inductive abili-
ties (see Figure 4B-E red and teal bars).y genes in the frog embryo. After animal pole injection of XSmad1 or
ion of genes downstream of the BMP pathway. (A) Depiction of the
or RT-PCR when control embryos reached mid-gastrulation (Niewkoop
jected and uninjected whole embryos (L = Benchmark protein ladder,
translation, whereas the uninjected embryos show no background
of BMP pathway response genes Vent1, Vent2, Msx1, and Xhox3
ps (UN), animal caps injected with XSmad1, and animal caps injected
induction compared to endogenous whole embryo (1.0). Error bars
Figure 4 NvSmad2 induces expression of downstream Activin/Nodal pathway genes in Xenopus. Animal caps injected with XSmad2,
XSmad3, dSmad2, or NvSmad2 mRNA at the two-cell stage show elevated expression of genes downstream of the Activin/Nodal pathway.
(A) Western blot showing tagged protein translation levels in injected and uninjected whole embryos (L = Benchmark protein ladder, showing
the 58-kDa band). XSmad2, XSmad3, NvSmad2/3, and dSmad2 show equal levels of translation, whereas uninjected embryos show no
background signal. Real-time quantitative PCR (RT-PCR) shows fold induction levels of Activin/Nodal pathway members on the Y-axis. (B) Class I
markers goosecoid and anti-dorsalizing morphogenetic protein (ADMP). (C) Class II markers chordin, noggin, follistatin, and eomesodermin. (D) Class III
markers mixer, mix.2, and sox17α. (E) Class IV marker Xbra. (F) Xbra induction response to 2 ng, 5 ng, and 10 ng XSmad2 or NvSmad2/3. See text
for discussion of marker classes.
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AR-Smad orthologs. We chose the Drosophila AR-Smad
dSmad2 as a protostome representative and XSmad3 as
the second vertebrate AR-Smad ortholog. Upon repeat-
ing these experiments with all four treatments, further
trends became evident. We were able to split Activin/
Nodal markers into four classes based upon their in-
ductive response. Class I included goosecoid and ADMP,
two genes expressed strictly in the Spemann organizerof the developing amphibian. Both of these were strongly
induced by XSmad2 and less so by the other orthologs
(Figure 4B). Class II markers were induced strongly by
XSmad2 and dSmad2, and responded poorly to XSmad3
and NvSmad2/3 (Figure 4C). Class II included three
BMP-inhibitors - chordin, noggin, and follistatin, as well
as eomesodermin, another gene associated with dorsaliza-
tion. In contrast, Class III markers were induced strongly
by XSmad3, while XSmad2, NvSmad2/3, and dSmad2
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markers are more general mesendoderm-related Activin/
Nodal markers mix2, mixer, and sox17α.
Xbrachyury was in a class by itself, Class IV
(Figure 4E). Xbra induction by Smad2/3 orthologs was
generally low. The highest induction was by NvSmad2/3
and reached almost 60% of endogenous level in the
Xenopus embryo (1.0 on the Y-axis in all RT-PCR ana-
lyses). To test whether we were experimenting at the
appropriate dosage (4 ng), we compared three different
dosages of NvSmad2/3 and XSmad2 - 2 ng, 5 ng, and
10 ng. Results were similar; NvSmad2/3 induced more
strongly, while XSmad2 induced very weakly (Figure 4F).
Xbra response to the lower doses of NvSmad2/3 remained
consistent with previous results, while Xbra response to
the highest dose of NvSmad2/3 dropped to the low level
of Xbra response to XSmad2.
Substituting the NvSmad2/3 MH2 with the XSmad2 MH2
increases inductive capability
The Smad2/3 orthologs showed very particular induc-
tion patterns in our Xenopus animal cap assays. We
wished to determine whether the differences in activity
between XSmad2 and NvSmad2/3 might reflect evolu-
tionary specialization of specific regions of XSmad2, par-
ticularly whether any single domain from XSmad2 could
increase the capability of NvSmad2/3 to induce orga-
nizer markers in Xenopus. To this end, we created three
chimeras that replaced the domains in NvSmad2/3 one
at a time with XSmad2 domains (Figure 5A), and tested
their inductive abilities in animal cap assays with the
same set of markers as above. We confirmed equal
translation levels with western blotting before RT-PCR
(Figure 5B) [see Additional file 4 for western blot load-
ing controls]. The linker chimera (‘Link’ in Figure 5B)
showed a slightly lower amount of protein than the
others at 4 ng mRNA injection. It remained at a lower
level even at 8x the injection concentration of the other
treatments (data not shown), so we kept the injection
concentrations equal.
Interestingly, the four classes of markers from our pre-
vious experiment were largely consistent in this experi-
ment as well. In Class I markers goosecoid and ADMP,
substitution of the XSmad2 MH2 domain (“MH2
chimera”) led to a gain in inductive ability over the wild
type NvSmad2/3, to about 50% of the level of XSmad2
induction (Figure 5C). For Class II markers chordin,
follistatin, and eomesodermin, the MH2 chimera showed
very slight enhancement in inductive ability, but that was
still only a fraction of the level of induction observed
with XSmad2 (Figure 5D). For Class III markers,
NvSmad2/3 inductive ability was already slightly higher
than that of XSmad2, and the MH2 chimera showed a
modest increase (Figure 5E). For Xbra, the Class IVmarker, the MH2 chimera had significantly less in-
ductive activity than NvSmad2/3 (Figure 5F).
In all cases, substitution of the XSmad2 MH1 domain
(‘MH1 chimera’) had a negative effect on the inductive
capacity of NvSmad2/3 (Figure 5C-F). Likewise, swap-
ping in the XSmad2 linker region for the NvSmad2/3
linker region (‘linker chimera’) resulted in a drop in in-
ductive ability of nearly every marker tested. Again,
Xbra showed its own unique response pattern; it was
the only marker to respond more strongly to the linker
chimera than to the wild type NvSmad2/3 (Figure 5F).
The Xbra response levels to wild type XSmad2 and
NvSmad2/3 correspond to our previous dosage observa-
tions (Figure 4E).
NvSmad2/3 does not induce the formation of a second
body axis when ectopically expressed in Xenopus
embryos
NvSmad2/3 shows a complicated activity pattern in re-
gard to its induction of dorsal mesoderm markers and
Activin/Nodal targets. This calls into question the level
of Smad2/3 functional conservation within Metazoa. It
has been shown previously that Smad2 from the mouse
can induce a second body axis in Xenopus embryos [31],
one with trunk and tail characteristics but lacking a
head. This is nearly identical to axial structures induced
by ectopically-expressed Xenopus activin [32] and indi-
cates that Smad2 function is conserved among vertebrates.
We performed ectopic expression experiments to deter-
mine whether the ability to induce a second body axis is
unique to the vertebrate Smad2 ortholog. Alternatively,
that ability could be inherent to both of these vertebrate
Smad2/3 paralogs, to all bilaterian Smad2/3 orthologs, or
more generally to all metazoan Smad2/3 orthologs.
We observed a very strong secondary axis phenotype
caused by bilaterian Smad2/3 orthologs (Figure 6A-D).
The secondary axis was evident as a second set of neural
folds at neurula stage (Figure 6G-K) and developed into
an unmistakable secondary trunk by tadpole stage
(Figure 6B, white arrowheads). XSmad2 produced a se-
condary axis in 65% of embryos, whereas XSmad3 did so
in about 50% of embryos, and dSmad2 in 45%
(Figure 6L). In another 25 to 35% of cases, both proteins
did not generate a distinct secondary axis, but did create
a small “incipient” second axis at the neurula stage (for
example, Figure 6J) that was subsumed into the primary
axis during development and eventually manifested as
the ‘perturbed’ axis of the tadpole [see Additional file 6].
NvSmad2/3 did not effectively produce a secondary
axis, but it did perturb the primary axis in 25% of
embryos (Figure 6E). NvSmad2/3 did appear to generate
a secondary body axis in one embryo (n = 88), but it was
from a relatively unhealthy batch of embryos and this
example was not representative of the overall performance
Figure 5 Swapping in the MH2 domain from XSmad2 increases the inductive activity of NvSmad2/3. (A) Design of chimeras swapping
XSmad2 domains into NvSmad2/3. (B) Western blot showing tagged protein translation levels in injected and uninjected whole embryos
(L = Benchmark protein ladder, showing the 58-kDa band). XSmad2, XSmad3, NvSmad2/3, MH1 chimera, and MH2 chimera show equal levels of
translation, whereas the uninjected embryos show none. The linker chimera (‘Link’) shows slightly lower levels of translation. Note, XSmad3 was
injected and included in translation blot to check continuity with previous experiments, but was not used in subsequent animal cap analyses.
Animal caps injected with XSmad2, NvSmad2, MH1 chimera, linker chimera, or MH2 chimera mRNA at the two-cell stage show elevated
expression of genes downstream in the Activin/Nodal pathway. Real time quantitative PCR shows fold induction levels of Activin/Nodal pathway
members on the Y-axis. (C) Class I markers goosecoid and ADMP. (D) Class II markers chordin, noggin, follistatin, and eomesodermin. (E) Class III
markers mixer, mix.2, and sox17α. (F) Class IV marker Xbra.
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the ability of NvSmad2/3 to produce a secondary body
axis, but it perturbed the natural axis in upwards of 50%
of embryos (Figure 6F, L).
These data agree with other data we present here
that suggest that bilaterian Smad2/3 orthologs have
developed functions that non-bilaterian orthologs are un-
able to perform in vivo. These data also support ourresults indicating that swapping XSmad2 domains onto
NvSmad2/3 cannot bestow full functional abilities.
NvSmad1/5, but not NvSmad2/3, can recapitulate activity
of bilaterian orthologs
NvSmad1/5 engaged the Xenopus pathway well enough
to cause very severe ventralized phenotypes (Figure 2)
and activate transcriptional targets (Figure 3), although
Figure 6 (See legend on next page.)
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Figure 6 Ectopic overexpression of NvSmad2/3 does not induce a secondary axis in Xenopus embryos. Injection of 0.5 ng XSmad2 mRNA
into the marginal zone of one ventral vegetal blastomere at the 8-cell stage can produce a secondary body axis in Xenopus embryos.
(A) Uninjected, wild type tadpoles. (B) Tadpoles that were injected with XSmad2 show a classic secondary body axis phenotype (marked with
white arrowheads in this photo only). (C) Injection of XSmad3 shows a clear secondary axis. (D) dSmad2 is able to induce the formation of a
second body axis. (E) NvSmad2/3 is not able to generate a second body axis, but can perturb the original axis. (F) The MH1 chimera acutely
perturbs the original axis, but generates a complete second axis in only a few cases. Embryos were scored for axial phenotypes at neurula stage.
Examples: (G) wild type, (H) double axis that would result in a second body axis at tadpole stage (result of XSmad2 mRNA, in this case),
(I) another double axis (caused by dSmad2 mRNA, in this case), (J) ‘incipient’ axis that will eventually get subsumed into the primary axis and
result in the ‘perturbed axis’ phenotype (result of XSmad3 mRNA, in this case, though it could be caused by any of the treatments),
(K) phenotype that would be scored as ‘wild type’ (result of NvSmad2/3 mRNA, in this case). (L) Bar graph illustrating the range of phenotypes
from each treatment. See Additional file 6 for more photos illustrating the ‘perturbed axis’ phenotype.
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pression of NvSmad2/3 was unable to induce a second-
ary axis in Xenopus embryos, and showed differences in
downstream induction of Activin/Nodal markers when
compared to XSmad2, including the BMP inhibitors nog-
gin, chordin, and follistatin, and the organizer-specific
genes goosecoid and ADMP. All of these except ADMP
are known to have cnidarian orthologs [33]. Interest-
ingly, NvSmad2/3 induced the general mesendoderm
markers at the same level as some of the bilaterian
orthologs (Class III, Figure 4D). There is no ortholog of
nodal known in Nematostella, but NvActivin is
expressed in the endoderm during gastrulation [33].
Likewise, the Sox17 ortholog NvSoxF1 is expressed
broadly in the endoderm following gastrulation (there
are no definitive orthologs of mix2 or mixer yet known
to be expressed in developing Nematostella endoderm)
[34]. Our data are further evidence that Activin signaling
via AR-Smads to pattern endoderm is an ancient and
conserved mechanism in metazoan development.
One alternative explanation for the differential activation
of gene targets by NvSmad2/3 in our experiments could be
a dose-dependence. Experiments incubating Xenopus ani-
mal caps with Activin ligand have revealed striking dose-
dependent induction of mesodermal markers including
Xbra and goosecoid by Activin, which are activated at
low and high doses of Activin respectively [35,36]. We
observed a concordant Xbra dose-dependent response to
ligand-independent overexpression of either Xenopus or
Nematostella Smad2/3 (Figure 4F and results not shown).
We reasoned that if the particular dose of Smad2/3 was
responsible for these differences in gene induction, then
programming the animal cap system with graded concen-
trations of NvSmad2/3 (up to 10 ng) might yield sufficient
activity to replicate the inductive patterns observed with
XSmad2 (for example, induction of Xbra and Xgsc at re-
spectively low and high levels of NvSmad2/3). To the con-
trary, however, the response patterns of most markers
remained consistent for all three doses tested (Additional
file 7). Increasing the level of NvSmad2/3 to 10 ng did not
activate the goosecoid gene even to a level induced by the
lowest amount of XSmad2 (see Additional file 7).We propose that the differences in cnidarian versus
bilaterian Smad2/3 activity reflect evolutionary diver-
gence, which has rendered NvSmad2/3 unable to engage
the necessary signaling, transcriptional, or other neces-
sary cofactors in the Xenopus system. This may be due
to lack of key microdomains or amino acid residues that
are present in Xenopus and other bilaterian Smad2/3
orthologs which facilitate more efficient or complete en-
gagement and activation of target genes. For instance,
Smad2 and Smad3 proteins make complexes with
Smad4, FAST-1, p53 and other co-factors in order to
enter the nucleus, bind DNA, and transcribe target
genes [13,35,37]. The low inductive activity of
NvSmad2/3 in Xenopus could be due to NvSmad2/3
forming transcriptional complexes that are weak, un-
stable, and/or inactive. Smads are also a common target
of TGFβ signal regulation by other pathways, such as
FGF (via MAPK) and Wnt (via GSK3) [36], thus there
are various ways in which the subtle protein sequence
differences between NvSmad2/3 and vertebrate Smad2
and 3, especially those in the linker domain, could lead
to differences in activity.
Despite the low inductive ability of NvSmad1/5 rela-
tive to XSmad1, it could still re-pattern the Xenopus
embryo to cause severe significant ventralization of dor-
sal tissues. This was not the case with NvSmad2/3,
which could not induce the secondary body axis
observed with overexpression of XSmad2, XSmad3, or
dSmad2 (Figure 6E, G). Mouse Smad2 can also generate
a very pronounced second axis in Xenopus embryos [31],
which builds the case that bilaterian Smad2/3 orthologs
have a function that the non-bilaterian NvSmad2/3 is
not able to perform. This suggests fine-scale divergence
in the case of Smad1/5 and larger-scale divergence in
the evolutionary history of Smad2/3.
Vertebrate Smad2 and Smad3 have different activity
There are numerous indicators that vertebrate Smad2
and Smad3 have different activities. There is evidence of
exclusive co-factors for each in zebrafish [38], and verte-
brate Smad2 and Smad3 differ in their mechanisms of
nuclear import and their regulation by ubiquitination
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our animal cap assays also suggest a division of labor.
Most significantly, XSmad2 shows greater transactiva-
tion of markers associated with the Spemann organizer,
particularly genes encoding dorsalizers such as the BMP
inhibitors chordin, noggin, and follistatin. XSmad3, on
the other hand, is more efficient in the activation of ge-
neral mesendodermal genes such as mix2 and mixer,
and the endoderm-specific gene sox17α (Figure 4C).
This division of labor agrees with the observations that
Smad3 might be more involved in TGFβ-mediated cell
cycle control in some cell lines, reflected by the findings
that mutations in Smad3 are more prevalent in some
types of cancer [13]. Mouse gene knockout phenotypes
also indicate that Smad2 may have a greater role than
Smad3 during embryonic development, with Smad3
contributing more to the regulation of cell stasis [15].
NvSmad2/3 has comparable inductive ability to
XSmad3 (stronger with mesendodermal genes, weaker
with organizer-related genes), whereas XSmad2 and
dSmad2 show similar inductive ability (stronger with
organizer-related genes, weaker with mesendodermal
genes). This makes it tempting to propose that XSmad3
retains deep ancestral function similar to NvSmad2/3;
however, functional testing showed that XSmad3 pro-
duces a secondary body axis in the same manner as
XSmad2 and dSmad2, while NvSmad2/3 does not
(Figure 6L). This creates a very complicated picture of
Smad3; it has the ability to control the embryonic orga-
nizing center and induce dorsal tissue fates as well as
Smad2, but in vitro it shows more affinities for induction
of mesendoderm-related genes. We infer that the
Smad2/3 progenitor may have acquired its ability to con-
trol the evolving vertebrate organizer before the duplica-
tion event, and that the ‘division of labor’ after the
duplication event appears to be superficial, affecting the
protein’s activity rather than its actual function.
One important contributor to this division of labor be-
tween vertebrate Smad2 and Smad3 may have been the
evolution of exon 3 in vertebrate Smad2. This exon
encodes a 30-amino acid insertion positioned within the
MH1 domain immediately adjacent to the predicted
DNA-binding hairpin [see Additional file 1]. This inser-
tion prevents proper DNA binding by Smad2, but
Smad3, lacking this insert, binds DNA. Interestingly, an
alternatively spliced version of Smad2 mRNA encodes a
protein that does not include exon 3 (known as Smad2-
ΔExon3) and this variant of Smad2 has been shown to
bind to DNA [40]. Smad2ΔExon3 splice variant tran-
scripts and protein have been found in gastrula stage
Xenopus embryos [41], and various mammalian cell
lines. We have tested the ability of Xenopus Smad2-
ΔExon3 to activate Activin/Nodal signaling markers, and
our results indicate that the activity of XSmad2ΔExon3is, more similar to that of XSmad3 and NvSmad2/3 than
it is to XSmad2 (Figure 7). The functional importance of
exon 3 in Smad2 signaling, and its origin during verte-
brate evolution merits further analysis in the future.
The MH2 domain has the largest influence on R-Smad
induction capability
The results of our chimeric R-Smad analysis underscore
the importance of the MH2 domain as a determinant of
gene activation, and illustrate an interesting aspect of se-
quence conservation versus signaling activity. The MH2
domain is the most conserved protein domain between
R-Smad orthologs from various species (Figure 1B) [see
Additional file 1], yet despite this high degree of se-
quence conservation, replacement of the MH2 domain
in NvSmad2/3 with the XSmad2 MH2 shows the great-
est enhancement of NvSmad2/3 activity (Figure 5C, D).
This points to the importance of the few amino acid
residues that vary between the MH2 domains of Xen-
opus and Nematostella proteins, which may not be
revealed by natural mutagenesis (for example, cancer
mutations) or directed changes. These types of substitu-
tions are most frequently reported in the MH2 when
they have a significant effect on Smad signaling, such as
those of the loop-strand pocket that are involved in re-
ceptor docking and specificity [42], those in the co-factor
binding hydrophobic pocket [43,44], or those essential to
Smad trimerization [45,46]. Our observed patterns of dif-
ferential downstream gene induction between species are
more subtle than these large effects, and indeed, in the
great majority of cases, residues that are reported to be
functionally important are conserved across species
(Additional file 1). To reveal which residues contribute
to the induction patterns reported here, we suggest fur-
ther experimentation with chimeric constructs, especially
single amino acid replacements of positions known for
greater variability.
In contrast to MH2, the MH1 chimera did not im-
prove the signaling capacity of wild type NvSmad2/3
(Figure 5C-E). One likely reason for this is that the ver-
tebrate Smad2 MH1 domain lacks the ability to bind
DNA. As noted above, vertebrate Smad2 differs from
Smad3 and all other Smad2/3 orthologs due to the
30-amino acid insert (coded by exon 3) preceding the
DNA binding domain of the MH1 between the L2 loop
and the β-hairpin (see Additional file 1). In Smad4, mu-
tating amino acids in this region severely disrupts DNA
binding [40,47], and deletion of exon 3 from XSmad2,
in the natural splice variant XSmad2ΔExon3 signifi-
cantly altered its signaling activity in animal caps
(Figure 7). Besides the exon 3 insert in XSmad2, the
first five amino acids of the L2 loop itself are different in
NvSmad2/3 and XSmad2. It would be informative to








































































Figure 7 XSmad2ΔExon3 induces expression of downstream Activin/Nodal pathway genes in a pattern resembling XSmad3 rather
than full-length XSmad2. Animal caps from gastrulae that had been injected with XSmad2, XSmad2ΔExon3, XSmad3, dSmad2, or NvSmad2
mRNA at the two-cell stage showed elevated expression of genes downstream of the Activin/Nodal pathway. With all markers, the expression
patterns induced by XSmad2ΔExon3 (orange column) were more similar to that of XSmad3 (green column) and NvSmad2/3 (teal column) than
to full length XSmad2 (red column). (A) Class I marker goosecoid. (B) Class II markers chordin, noggin, and eomesodermin. (C) Class III markers mixer
and mix.2.
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lity and test whether there is a difference in down-
stream gene expression or ability to induce a second
axis by XSmad2.
In general, replacing the NvSmad2/3 linker region
with that of XSmad2 decreased its inductive ability.
Given the low protein level of the linker chimera relative
to the other Smad2/3 proteins we assayed (Figure 5B,
last column), the XSmad2 linker domain may destabilize
the NvSmad2/3 protein structurally or by introduction
of additional sequences that direct post-translational
modifications. The NvSmad2/3 linker lacks motifs that
are essential for these regulatory processes (Figure 1D),
including a proline-proline-X-tyrosine (PPXY) consensus
motif targeted by Smad ubiquitin-ligases such as Smurf2
[26,48]. Interestingly, we were unable to identify clear
Smurf1 or Smurf2 orthologs in the Nematostella ge-
nome or ESTs, which appears to correspond to the ab-
sence PPXY motifs in either Nematostella Smad.
Addition of the Xenopus linker is predicted to cause
NvSmad2/3 to undergo a more complex level of regula-
tion in vivo in Xenopus embryos than wild typeNvSmad2/3 might in the sea anemone, likely making the
chimera sensitive to Smurf2 or NEDD4-L mediated ubi-
quitylation and degradation.
Despite its apparent lack of activity on many endoge-
nous Xenopus genes, the linker chimera induced down-
stream Activin/Nodal target genes eomesodermin, mix.2,
and Xbra at levels that approach or exceed those
observed in the uninjected whole embryo (Figure 5D, E).
This indicates that the linker chimera is not simply non-
functional, but instead that its unique combination of se-
quence features renders it suited to induce only a subset
of Activin/Nodal response genes. To address this possi-
bility, it would be interesting to point-mutate some of
the specific kinase target residues in the NvSmad2/3
linker to create sites that confer vertebrate-like linker
regulation, and test the activities of such mutants. This
would help distinguish the effects of linker-driven post-
translational regulation from transcriptional activity of
the Nematostella nd Xenopus proteins. Conversely, it
would be interesting to replace the XSmad2 linker with
that of NvSmad2/3 and test whether the decrease in
linker regulation sites has any effect on the ability of
Sorrentino et al. EvoDevo 2012, 3:22 Page 15 of 17
http://www.evodevojournal.com/content/3/1/22XSmad2 to activate target marker genes. Our results
raise interesting questions about the evolution of R-
Smad functions during metazoan diversification. For ex-
ample, we would like to understand how differences in
R-Smad protein sequences correlate with the acquisition
or loss of target genes (and protein cofactors) among
testable species in major taxonomic clades, particularly
at nodes where Smad gene duplications have occurred
or where Smad signaling pathway complexities have
been streamlined by genome reduction. This would re-
quire a greater breadth of in vivo functional tests, assay-
ing activities of orthologous Smads between species. A
desirable next extension of the present study would be
to test wild-type orthologs and chimeric R-Smads in
Nematostella embryonic assays (and ideally Drosophila
embryos as well). Such tests would provide additional in-
formation about the evolution of Smad structure and
function as well as provide important information about
the biological actions of Smad signals in cnidarian germ
layer specification and cell fate determination.
Conclusions
In this study we compared and contrasted the signaling
activities of the two R-Smads of Nematostella with their
bilaterian orthologs, in the context of a developing verte-
brate. We find that the BMP-specific R-Smad, NvSmad1/
5, can pattern (ventralize) the mesoderm of Xenopus laevis
embryos and activate downstream genes in a similar, albeit
less efficient, manner than a vertebrate ortholog, Xenopus
Smad1. This speaks to a deep conservation of function
within the BMP pathway of bilaterians and earlier-
diverging metazoan groups. Further, we find that the
Activin R-Smad, NvSmad2/3, is a strong inducer of
mesendodermal and definitive endoderm genes, suggest-
ing that the development of endoderm via Smad2/3 sig-
naling is also an ancient and conserved system. However,
the cnidarian NvSmad2/3 fails to induce a secondary body
axis in Xenopus embryos and is inconsistent in its ability
to activate downstream target genes compared to its bila-
terian counterparts XSmad2, XSmad3, and the sole Dro-
sophila AR-Smad, dSmad2.
Based on our results and previous reports, we propose
that the bilaterian ancestor solidified a novel role for the
Smad2/3 ortholog in controlling body patterning that the
NvSmad2/3 is unable to perform. Furthermore, our ani-
mal cap assays are the first to test the inductive activities
of Smad2 and Smad3 side by side, and indicate different
target gene affinities for the two, with XSmad2 having sub-
stantially greater effects on organizer-specific genes than
general mesendodermal genes, whereas XSmad3 displays
converse actions. This demonstrates an intriguing division
of labor that leads us to suggest that vertebrate Smad2 has
evolved novel activities that govern the vertebrate orga-
nizer. Compellingly, the division of labor between theseduplicates is relatively “superficial,” being that both verte-
brate AR-Smads and the Drosophila ortholog dSmad2 are
capable of patterning dorsal tissues and inducing a se-
condary axis in Xenopus embryos.
The MH2 domain has a major influence on AR-Smad in-
ductive capability, yet this domain is 96% identical in
XSmad2 and XSmad3, highlighting the importance of par-
ticular residues whose random mutation is not lethal to the
organism, but may instead bring about slight functional
changes that can be selected on and affect evolutionary di-
vergence. Activity tests on a more comprehensive set of R-
Smad orthologs gathered from major taxonomic groups
should be very informative about the evolution of R-Smad
structure/function and target gene regulation.
Additional files
Additional file 1: Protein sequence alignments of R-Smad
orthologs. The alignment highlights functionally and structurally
important residues and regions present in R-Smads. In the MH1 domain
(orange), there is a nuclear localization signal (brick red), a DNA binding β
hairpin (teal), and residues that make up some or most of the
hydrophobic core of the molecule (purple) [46]. Four residues coordinate
a zinc atom at the center of the molecule (green triangles) [49]. In the
MH2 domain (pink), there are sites of trimer stabilization (lilac), residues
that are critical for trimerization contacts (green stars), residues that
contribute to a hydrophobic pocket (blue stars) to bind a cysteine from
an adjacent Smad molecule (open blue star), a ‘loop strand pocket’
involved with macromolecular interactions (moss green), and two
C-terminal serines which are phosphorylated to activate the R-Smad
(yellow diamonds) [45]. The loop strand pocket of the MH2 region also
contains several residues that bestow receptor specificity [42]. Blue and
red boxes indicate residues that are sub-type specific between R-Smads
[50]. Important residues in the linker region have already been discussed
in detail in Figure 1. Note that this is not meant to be a comprehensive
list of R-Smad proteins across phyla or of all residues contributing to
R-Smad structure or function; please consult references for studies of
these and other proteins and functional sites.
Additional file 2: Table of accession numbers and details about
proteins used in the alignments. Details of the orthologs of R-Smads
from human, Xenopus laevis, Drosophila melanogaster, and Nematostella
vectensis used in this analysis.
Additional file 3: Primer sequences and experimental PCR design
to create the chimeric constructs. The table contains all primers to
create all sections of each of the three chimeric constructs. The diagram
shows the primers used to amplify particular sections of the constructs.
Full constructs were amplified from combined sections by PCR with
end-point primers. Relative lengths of the constructs are depicted. See
Methods sections for a full explanation of design and method.
Additional file 4: Loading controls for western blots. Protein
translation levels were detected with an antibody to the HA tags of the
HA-RSmads expressed from mRNA made in vitro from the pCS2
expression vector. (A) From left to right: protein ladder, XSmad1,
NvSmad1, and uninjected control embryos. The non-specific band signals
indicate equal protein loading on the gel (blue arrow). (B) Left to right:
protein ladder, XSmad2, XSmad3, dSmad2, NvSmad2/3, and uninjected
control. 40 kDa β-Actin loading control band can be seen where
indicated (blue arrow). (C) Left to right: protein ladder, water injection
(control), uninjected embryo, XSmad2, XSmad3, NvSmad2/3, MH1
chimera, MH2 chimera, and linker chimera. Non-specific bands indicate
equal loading across the gel (blue arrow).
Additional file 5: Table of RT-PCR primers used on the Roche 480
Light Cycler system. All of the primers used in our animal cap gene
induction assays are provided, with published conditions and references.
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‘perturbed axis’ phenotypes. Examples of the ‘perturbed axis’
phenotype in tadpoles at stages 33 to 34. This phenotype was observed
at some level by any of the treatments in our experiments.
Additional file 7: Dosage experiments with three concentrations of
XSmad2 and NvSmad2/3. Dosage experiments showed that increasing
or decreasing the mRNA concentration does not significantly change the
gene induction patterns produced by XSmad2 and NvSmad2/3 in animal
cap assays.
Abbreviations
ADMP: Anti-dorsalizing morphogenetic protein; AR-Smad: Activin-Nodal
Pathway smad; BMP: Bone morphogenetic protein; BR-Smad: an R-Smad in
the BMP pathway; Co-Smad: Common smad; DAI: DorsoAnterior Index;
EST: Expressed sequence tag cDNA; I-Smads: Inhibitory smads; MAPK: Map
kinase; MH: MAD homology domains in Smad proteins; PXSP: Proline-any-
serine-proline peptide consensus; qPCR: Real-time quantitative RT-PCR;
R-Smads: Receptor-regulated smads; RT-PCR: Reverse-transcriptase
polymerase chain reaction; TGFβ: Transforming growth factor-β.
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